Celmatix
→
Gedeon Richter
Acquisition · Cash · RICHTER · announced Mar 3, 2026
Announced
Mar 3, 2026
Economics
Undisclosed
Cash
Upfront payment + development milestones (terms not fully disclosed)
Target
Celmatix
Fertility · Clinical / therapeutic
HQ New York, NY · Founded 2009
Women's health biotech — oral FSH receptor agonist for fertility, JNK inhibitor for endometriosis, and AMH antibodies for ovarian aging
- Gedeon Richter press release (Mar 3, 2026)
- Budapest Stock Exchange filing
- Crunchbase - crunchbase.com/organization/celmatix
Acquirer
Gedeon Richter (RICHTER)
Reproductive Health
HQ Budapest, Hungary
Why this buyer
Curated copy from the verified dataset — not an 8-K LLM summary
Women's health drug discovery — oral FSH agonist for fertility, JNK inhibitor for endometriosis, AMH antibodies for ovarian aging; development led by Belgian R&D hub
Evidence ladder
Secondary (press / IR)
Gedeon Richter press release (Mar 3, 2026)
Tertiary (trade / analyst)
Budapest Stock Exchange filing
Limitations
- Citations are press/IR only — two wires of the same announcement are not dual-source. Add a primary filing.
- Deal value not disclosed in verified record; multiples and comparables exclude this transaction.
Valuation peers · Fertility
Same sector, same deal type, announced within ±3 years, disclosed value within 0.25×–4× of this transaction. Ranked by evidence class, then same acquirer, until you sort.
Insufficient disclosed data
No verified Fertility deals meet the peer rule: same deal type, announced within ±3 years, and a disclosed value inside 0.25×–4× of this transaction.
Other verified deals by Gedeon Richter
Acquirer program history not already listed as a valuation peer or adjacency row.
| Sector | ||||
|---|---|---|---|---|
| Estetra (Mithra assets) | Gedeon Richter | Jun 12, 2024 | Contraception |
Patient empowerment context
Patient empowerment baseline (HLTH 2022)
No curated mapping — Celmatix (Fertility). HLTH/Outcomes4Me 2022 baseline is Breast cancer care continuum (HLTH 2022). No curated mapping for this target in the verified crosswalk.
Research workspace (includes heuristic crosswalk) →Related verified workspaces
Lacuna is a curated public-source sample, not a census of women's-health M&A. Coverage varies by sector, geography, disclosure availability, and women's-health scope. Undisclosed transaction values are excluded from disclosed-value totals.
Curated verified dataset v11 · updated 2026-10-19 · 2 citations on this deal · Data compiled from public sources for educational visualization. Verify independently before any commercial use.